Weight loss drugs have been gaining popularity in recent years, with medications like ZepBound and WeGoBe becoming highly sought after by patients. However, the increasing demand for these drugs has led to a shortage, making it difficult for many individuals to access them. This shortage, coupled with the high list prices of these medications, has caused frustration among patients who are eager to try them.
According to reports, drugs like Ozempic and Wegovy, which fall into the new class of weight loss medicines, have experienced shortages alongside their skyrocketing prices. Even patients who meet the qualifying criteria based on their body mass index (BMI) are finding it challenging to obtain these drugs due to insurance coverage limitations. The list prices for these medications can reach nearly $1,000 per month, making them financially inaccessible for many.
